Obesity, high blood sugar surge in Indian adults, warns NFHS‑6 survey

IMT News Desk
IMT News Desk
· 2 min read
NFHS-6 shows a sharp rise in obesity & high blood sugar among Indian adults, signalling a growing lifestyle disease burden & urgent need for prevention.

India has witnessed a significant rise in obesity and high blood sugar levels among adults, according to preliminary findings from the National Family Health Survey‑6 (NFHS‑6), underscoring a growing burden of lifestyle‑related diseases.

The survey shows that 30.7% of women aged 15 to 49 years were overweight or obese in 2023- 24, up from 24% in NFHS‑5 conducted during 2019- 21, while the corresponding proportion for men increased from 22.9% to 27.3% in the same period.

NFHS‑6 also reports a substantial jump in elevated blood sugar levels among adults, a key risk factor for diabetes and cardiovascular disease. Among women aged 15 years and above, the share of those with high or very high blood sugar, or on medication to control it, rose from 13.5% in NFHS‑5 to 17.8% in NFHS‑6, while among men the figure increased from 15.6% to 20.9%.

Public health experts cited in the survey coverage link these trends to rapid urbanisation, sedentary lifestyles, unhealthy diets and rising stress levels, warning that India could see a further spike in non‑communicable diseases such as diabetes, heart disease and stroke if preventive action is not scaled up.

The findings come even as India records gains in some traditional health indicators, including improvements in child nutrition and maternal health outcomes, suggesting a complex “double burden” of undernutrition in some groups and over‑nutrition‑related disorders in others. Health policymakers and clinicians say the NFHS‑6 data should serve as a wake‑up call for strengthening primary care, screening for metabolic risk factors, and community‑level interventions around diet, physical activity and early management of obesity and high blood sugar.

Read Next

India’s first focused health AI Conclave unites doctors and AI experts
Featured Article
July 10, 2026

India’s first focused health AI Conclave unites doctors and AI experts

• Global Healthcare Academy hosts HAI Conclave 2026, India’s first national platform dedicated to Healthcare and Artificial Intelligence • Landmark Bengaluru conference brings together healthcare leaders and AI experts to explore how Artificial Intelligence can make healthcare faster, safer and more accessible while keeping patients at the centre of every decision The inaugural edition of the HAI Conclave […]
Article by: IMT News Desk
Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026
News
July 10, 2026

Fischer Medical Ventures Highlights NYB.AI Partnership as Platform Showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures Limited (FMVL) has announced that its strategic partner, Nanyang Biologics, has achieved a major international milestone with its AI-powered molecular research platform, NYB.AI, being featured in the opening showcase at NVIDIA GTC Taiwan 2026, ahead of the keynote address by NVIDIA Founder and CEO Jensen Huang. The recognition places NYB.AI among a […]
Article by: IMT News Desk
Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs
News
July 10, 2026

Pharma Q1 Margins Seen Under Pressure Despite Revenue Growth: Goldman Sachs

Indian pharmaceutical companies are expected to report healthy revenue growth in the first quarter of FY27, but margins are likely to compress as sector profitability comes under pressure. In a recent preview note, Goldman Sachs said it anticipates around 185 basis points year-on-year margin decline for the sector in the June quarter, driven primarily by […]
Article by: IMT News Desk
Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue
News
July 10, 2026

Dr Reddy’s Delays Semaglutide Supplies After Active Ingredient Quality Issue

Dr Reddy’s Laboratories has announced a delay in commercial supplies of its semaglutide product after certain batches were found to be out of specification due to an issue with the active pharmaceutical ingredient (API) used in the drug. The company said it has initiated an investigation into the root cause and is taking corrective measures […]
Article by: IMT News Desk